MedPath

Comparison of drugs Dexmedetomidine and Pentazocine-promethazine in patients undergoing tympanoplasty under sedatio

Phase 4
Not yet recruiting
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/03/063761
Lead Sponsor
All India Institute of Medical Sciences, Raipur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients with chronic otitis media mucosal type posted for tympanoplasty.

2.Patients who have given consent for study.

3.Patients of ASA-PS I- II

4.Patients in the age group of 18-65 years of either sex.

Exclusion Criteria

1.Patients undergoing mastiodectomy

2.Patients who are not willing for consent.

3.Patients of ASA-PS III, IV

4.Patients with known allergic history to local anaesthetics, dexmedetomidine, pentazocine and promethazine.

5.Patients with uncontrolled psychiatric illness.

Pregnancy.

6.Patients with history of seizure disorder,neuroleptic malignant syndrome, heart failure,renal or liver failure.

7.Special group of population protected by the law and requires additional permission beyond the participant’s consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary : To compare the pain and sedation among the groups. <br/ ><br>Timepoint: Upto 4 hours post operatively
Secondary Outcome Measures
NameTimeMethod
1.To compare recovery and immediate post operative outcome among the groups. 2.To compare patient’s comfort and surgeon’s satisfaction during surgery among the groups. <br/ ><br>3. To compare side effects and hemodynamic variations from baseline among both the drugs. <br/ ><br> <br/ ><br>Timepoint: Upto 4 hours postoperatively
© Copyright 2025. All Rights Reserved by MedPath